Position in RPRX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$29,380
+$4,628 QoQ
Shares Held
524
+1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#547
of 641 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026American Capital Advisory, LLC holds $90,620 across 24 Biotechnology names. RPRX ranks #1 (32.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
524 | $29,380 | |
| 2 | RLMD |
Relmada Therapeutics, Inc.
|
1,954 | $13,521 | |
| 3 | TECH |
BIO-TECHNE Corp
|
155 | $10,950 | |
| 4 | IBRX |
ImmunityBio, Inc.
|
1,227 | $10,742 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16 | $7,947 | |
| 6 | ARGX |
Argenx SE
|
3 | $2,783 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4 | $2,494 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7 | $2,107 |
All Filings in RPRX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,380 | 524 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $24,752 | 516 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $19,938 | 516 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $25,154 | 713 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $25,797 | 716 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $21,915 | 704 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $17,857 | 700 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $19,803 | 700 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $23,733 | 900 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $30,370 | 1,000 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $25,281 | 900 | Shares | Sole | 2024-04-09 | |
| No filing history on record for this holder in this stock. | ||||||